1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride

Catalog No. :
ACTPDU583
CAS No. :
374822-27-2
Molecular Formula :
C10H10ClF6N
Molecular Weight :
293.64

IUPAC Name:1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-amine hydrochloride

1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$60.00Login to see priceIn stockInquiry
5g97%$296.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride
IUPAC Name1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-amine hydrochloride
MDL No.MFCD04038875
Molecular FormulaC10H10ClF6N
Molecular Weight293.64
SMILESCC(N)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1.[H]Cl
InChI KeyDWSPCWWXKNPRFN-UHFFFAOYSA-N
Synonym1-[3,5-Bis(trifluoroMethyl)phenyl]ethanaMine Hydrochloride;1-[3,5-Bis(trifluoroMethyl)phenyl]ethanaMine HCl;alpha-Methyl-3,5-bis(trifluoromethyl)benzenemethanamine hydrochloride;1-(3,5-bis(trifluoromethyl)phenyl)ethan-1-amine hydrochloride;Benzenemethanamine, α-methyl-3,5-bis(trifluoromethyl)-, hydrochloride (1:1);1-[3,5-Bis(trifluoromethyl)phenyl]ethanamine Hydrochloride - [B94735]
CAS No.374822-27-2
PubChem CID22293563

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTPDU583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPDU583 route product structure diagram
    ACTPDU583374822-27-2 In Stock
Inquiry

2. ACTPDU583 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTPDU583 route product structure diagram
    ACTPDU583374822-27-2 In Stock
Inquiry

Comments (0)